Association between an interleukin-4 promoter polymorphism and the acquisition of CXCR4 using HIV-1 variants

AIDS

Volumn 17, Issue 7, 2003, Pages 981-985

  Kwa, David ^a   Van Rij, Ronald P ^a   Boeser Nunnink, Brigitte ^a   Vingerhoed, Jose ^a   Schuitemaker, Hanneke ^a,b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b SANQUIN RESEARCH   (Netherlands)

Author keywords

CXCR4; HIV; Host genetic factor; Interleukin 4

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; INTERLEUKIN 4;

ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DNA POLYMORPHISM; GENE SEQUENCE; GENETIC ANALYSIS; GENOTYPE; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEMORY CELL; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION MAPPING;

CD4-POSITIVE T-LYMPHOCYTES; COHORT STUDIES; DISEASE PROGRESSION; GENOTYPE; HIV INFECTIONS; HIV-1; HOMOSEXUALITY, MALE; HUMANS; INTERLEUKIN-4; LONGITUDINAL STUDIES; MALE; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); RECEPTORS, CXCR4; RETROSPECTIVE STUDIES;

EID: 0037541432     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200305020-00006     Document Type: Article

References (22)

1. Zhang Y-J, Dragic T, Cao Y, Kostrikis L, Kwon DS, Littman DR, et al. Use of coreceptors other than CCR5 by non-syncytium-inducing adult and pediatric isolates of human immunodeficiency virus type 1 is rare in vitro. J Virol 1998, 72:9337-9344.
2. Koot M, Keet IPM, Vos AHV, De Goede REY, Roos MThL, Coutinho RA, et al. Prognostic value of human immunodeficiency virus type 1 biological phenotype for rate of CD4+ cell depletion and progression to AIDS. Ann Intern Med 1993, 118:681-688.
3. Richman DD, Bozzette SA. The impact of the syncytium-inducing phenotype of human immunodeficiency virus on disease progression. J Infect Dis 1994, 169:968-974.
4. Connor RI, Sheridan KE, Ceradini D, Choe S, Landau NR. Change in coreceptor use correlates with disease progression in HIV-1-infected individuals. J Exp Med 1997, 185:621-628.
5. Clerici M, Hakim FT, Venzon DJ, Blatt S, Hendrix CW, Wynn TA, et al. Changes in interleukin-2 and interleukin-4 production in asymptomatic human immunodeficiency virus-seropositive individuals. J Clin Invest 1993, 91:759-765.
6. Meyaard L, Hovenkamp E, Keet IPM, Hooibrink B, De Jong IH, Otto SA, et al. Single cell analysis of IL-4 and IFN-gamma production by T cells from HIV infected individuals: decreased IFN-gamma in the presence of preserved IL-4 production. J Immunol 1996, 157:2712-2718.
7. Meyaard L, Otto SA, Keet IPM, Van Lier RAW, Miedema F. Changes in cytokine secretion patterns of CD4+ T cell clones in HIV-1 infection. Blood 1994, 84:4262-4268.
8. Maggi E, Mazzetti M, Ravina A, Annunziato F, De Carli M, Pesce AM, et al. Ability of HIV to promote a Th1 to Th0 shift and to replicate preferentially in Th2 and Th0 cells. Science 1994, 265:244-248.
9. Torres Y, Medrano FJ, Rey C, Calderon EJ, Sanchez-Quijano A, Lissen E, et al. Evidence for a role of T-helper type 2 cytokines in the acquisition of human immunodeficiency virus syncytium-inducing phenotype. Eur J Clin Invest 1998, 28:930-936.
10. Valentin A, Lu W, Rosati M, Schneider R, Albert J, Karlsson A, et al. Dual effect of interleukin 4 on HIV-1 expression: implications for viral phenotypic switch and disease progression. Proc Natl Acad Sci USA 1998, 95:8886-8891.
11. Wang J, Roderiquez G, Oravecz T, Norcross MA. Cytokine regulation of human immunodeficiency virus type 1 entry and replication in human monocytes/macrophages through modulation of CCR5 expression. J Virol 1998, 72:7642-7647.
12. Schuitemaker H, Kootstra NA, Koppelman MHGM, Bruisten SM, Huisman HG, Tersmette M, et al. Proliferation dependent HIV-1 infection of monocytes occurs during differentiation into macrophages. J Clin Invest 1992, 89:1154-1160.
13. Wang J, Harada A, Matsushita S, Matsumi S, Zhang Y, Shioda T, et al. IL-4 and a glucocorticoid up-regulate CXCR4 expression on human CD4+ T lymphocytes and enhance HIV-1 replication. J Leukoc Biol 1998, 64:642-649.
14. Rosenwasser LJ, Klemm DJ, Dresback JK, Inamura H, Mascali JJ, Klinnert M, et al. Promoter polymorphisms in the chromosome 5 gene cluster in asthma and atopy. Clin Exp Allergy 1995, 25 (suppl 2):74-78.
15. Nakayama EE, Hoshino Y, Xin X, Liu H, Goto M, Watanabe N, et al. Polymorphism in the interleukin-4 promotor affects acquisition of Human Immunodeficiency Virus type 1 syncytium-inducing phenotype. J Virol 2000, 74:5452-5459.
16. De Roda Husman AM, Koot M, Cornelissen M, Brouwer M, Broersen SM, Bakker M, et al. Association between CCR5 genotype and the clinical course of HIV-1 infection. Ann Intern Med 1997, 127:882-890.
17. Van Griensven GJP, De Vroome EMM, Goudsmit J, Coutinho RA. Changes in sexual behaviour and the fall in incidence of HIV infection among homosexual men. BMJ 1989, 298:218-221.
18. Koot M, Vos AHV, Keet RPM, De Goede REY, Dercksen W, Terpstra FG, et al. HIV-1 biological phenotype in long term infected individuals, evaluated with an MT-2 cocultivation assay. AIDS 1992, 6:49-54.
19. Sandford AJ, Chagani T, Zhu S, Weir TD, Bai TR, Spinelli JJ, et al. Polymorphisms in the IL4, IL4RA, and FCERIB genes and asthma severity. J Allergy Clin Immunol 2000, 106:135-140.
20. Centers for Disease Control. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR 1987, 36 (suppl 1):1S-15S.
21. Nakayama EE, Meyer L, Iwamoto A, Persoz A, Nagai Y, Rouzioux C, et al. Protective effect of interleukin-4 -589T polymorphism on Human Immunodeficiency Virus type 1 disease progression: relationship with virus load. J Infect Dis 2002, 185:1183-1186.
22. De Roda Husman AM, Blaak H, Brouwer M, Schuitemaker H. CCR5 cell-surface expression in relation to CCR5 genotype and the clinical course of HIV-1 infection. J Immunol 1999, 163:4597-4603.